Sharon L. Benoit

1.7k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Sharon L. Benoit is a scholar working on Infectious Diseases, Genetics and Virology. According to data from OpenAlex, Sharon L. Benoit has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Genetics and 3 papers in Virology. Recurrent topics in Sharon L. Benoit's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Sharon L. Benoit is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Sharon L. Benoit collaborates with scholars based in United States and United Kingdom. Sharon L. Benoit's co-authors include Marc Rubin, James D. Esinhart, Andrew Hill, Michael S. Simberkoff, David E. Martin, Pamela Hartigan, William A. O’Brien, John D. Hamilton, Joseph J. Eron and Joseph Quinn and has published in prestigious journals such as New England Journal of Medicine, Blood and Clinical Pharmacology & Therapeutics.

In The Last Decade

Sharon L. Benoit

7 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS

1996 595 citations William A. O’Brien, Pamela Hartigan et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon L. Benoit United States	5	1.0k	973	232	113	76	8	1.2k
Carla Pettinelli United States	10	775 0.8×	653 0.7×	173 0.7×	135 1.2×	46 0.6×	10	968
Joseph Quinn United States	11	1.3k 1.3×	1.0k 1.1×	351 1.5×	171 1.5×	135 1.8×	14	1.6k
James D. Esinhart United States	10	489 0.5×	486 0.5×	151 0.7×	88 0.8×	24 0.3×	15	868
Charles Craig United States	17	851 0.8×	747 0.8×	240 1.0×	65 0.6×	91 1.2×	38	1.1k
Anna Cruceta Spain	15	880 0.9×	796 0.8×	267 1.2×	162 1.4×	182 2.4×	30	1.1k
Nancy Ruíz United States	11	965 0.9×	859 0.9×	166 0.7×	159 1.4×	38 0.5×	21	1.1k
Vincent Meiffrédy France	14	561 0.5×	526 0.5×	136 0.6×	221 2.0×	23 0.3×	24	767
Cindy Vavro United States	15	1.4k 1.3×	1.1k 1.2×	284 1.2×	308 2.7×	72 0.9×	26	1.5k
Judith Millard United States	10	534 0.5×	410 0.4×	118 0.5×	84 0.7×	89 1.2×	15	647
Michael Wohlfeiler United States	14	758 0.7×	637 0.7×	280 1.2×	209 1.8×	81 1.1×	31	1.1k

Countries citing papers authored by Sharon L. Benoit

Since Specialization

Citations

This map shows the geographic impact of Sharon L. Benoit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon L. Benoit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon L. Benoit more than expected).

Fields of papers citing papers by Sharon L. Benoit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon L. Benoit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon L. Benoit. The network helps show where Sharon L. Benoit may publish in the future.

Co-authorship network of co-authors of Sharon L. Benoit

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon L. Benoit. A scholar is included among the top collaborators of Sharon L. Benoit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon L. Benoit. Sharon L. Benoit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Eron, Joseph J., Joseph Quinn, Joseph G. Jemsek, et al.. (2020). Treatment with lamivudine, zidovudine, or both in hiv-positive patients with 200 to 500 cd4+ cells per cubic millimeter. UNC Libraries.

2.

Kuritzkes, Daniel R., Joseph Quinn, Sharon L. Benoit, et al.. (1996). Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. AIDS. 10(9). 975–981. 153 indexed citations

3.

McLaren, C., et al.. (1996). Inter-Company Collaboration for AIDS Drug Development: perspective on combination studies. Antiviral Research. 29(1). 119–122. 1 indexed citations

4.

O’Brien, William A., Pamela Hartigan, David E. Martin, et al.. (1996). Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS. New England Journal of Medicine. 334(7). 426–431. 595 indexed citations breakdown →

5.

Yuen, Geoffrey J., Sharon L. Benoit, & Marc Rubin. (1996). Population (POP) Pharmacokinetics (PK) of Lamivudine (3TC) in HIV Infected Patients: Results from Two Phase III Clinical Trials. Clinical Pharmacology & Therapeutics. 59(2). 144–144. 2 indexed citations

6.

Eron, Joseph J., Sharon L. Benoit, Joseph G. Jemsek, et al.. (1995). Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter. New England Journal of Medicine. 333(25). 1662–1669. 418 indexed citations

7.

Merigan, T. C., et al.. (1991). Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group. Blood. 78(4). 900–906. 32 indexed citations

8.

Merigan, T. C., et al.. (1991). Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group. Blood. 78(4). 900–906. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact